BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
+14%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$5.23T
AUM Growth
+$486B
(+10%)
Cap. Flow
+$960M
Cap. Flow
% of AUM
0.02%
Top 10 Holdings %
Top 10 Hldgs %
28.22%
Holding
5,601
New
192
Increased
2,077
Reduced
2,507
Closed
189
Top Buys
| 1 |
Capital One
COF
|
+$4.84B |
| 2 |
Amazon
AMZN
|
+$2.06B |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.01B |
| 4 |
Apple
AAPL
|
+$1.77B |
| 5 |
Broadcom
AVGO
|
+$1.39B |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
+$3.51B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.97B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.65B |
| 4 |
Palantir
PLTR
|
+$1.5B |
| 5 |
Texas Instruments
TXN
|
+$1.44B |
Sector Composition
| 1 | Technology | 31.15% |
| 2 | Financials | 13.27% |
| 3 | Consumer Discretionary | 10.11% |
| 4 | Healthcare | 9.81% |
| 5 | Industrials | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIM
2026
Chimera Investment
CIM
$1.15B
| $99.8M | ﹤0.01% |
7,198,526
-293,727
| -4% | -$4.07M |
|
|
EVRI
2027
DELISTED
Everi Holdings
EVRI
| $99.6M | ﹤0.01% |
6,991,316
-123,630
| -2% | -$1.76M |
|
2028
NextNav
NN
$2.3B
| $99.5M | ﹤0.01% |
6,544,863
+266,516
| +4% | +$4.05M |
|
2029
AMC Entertainment Holdings
AMC
$1.44B
| $99.4M | ﹤0.01% |
32,065,689
+2,114,438
| +7% | +$6.55M |
|
2030
TriCo Bancshares
TCBK
$1.48B
| $99.2M | ﹤0.01% |
2,451,173
-119,250
| -5% | -$4.83M |
|
2031
iShares 3-7 Year Treasury Bond ETF
IEI
$16.9B
| $99.2M | ﹤0.01% |
833,249
+277,270
| +50% | +$33M |
|
2032
Owens & Minor
OMI
$412M
| $99.1M | ﹤0.01% |
10,894,769
-615,275
| -5% | -$5.6M |
|
2033
Alpha and Omega Semiconductor
AOSL
$853M
| $99M | ﹤0.01% |
3,857,954
+89,160
| +2% | +$2.29M |
|
2034
Helen of Troy
HELE
$554M
| $98.9M | ﹤0.01% |
3,485,966
-15,162
| -0.4% | -$430K |
|
2035
Independent Bank Corp
IBCP
$657M
| $98.8M | ﹤0.01% |
3,048,888
-40,257
| -1% | -$1.3M |
|
2036
Amneal Pharmaceuticals
AMRX
$3.14B
| $98.1M | ﹤0.01% |
12,131,359
-456,419
| -4% | -$3.69M |
|
2037
Vera Therapeutics
VERA
$1.52B
| $98.1M | ﹤0.01% |
4,165,540
+173,003
| +4% | +$4.08M |
|
2038
Syndax Pharmaceuticals
SNDX
$1.34B
| $97.9M | ﹤0.01% |
10,456,907
+1,914,656
| +22% | +$17.9M |
|
2039
Ocular Therapeutix
OCUL
$2.23B
| $97.9M | ﹤0.01% |
10,546,379
-1,466,018
| -12% | -$13.6M |
|
2040
Ouster
OUST
$1.67B
| $97.8M | ﹤0.01% |
4,034,627
+409,954
| +11% | +$9.94M |
|
2041
Angi Inc
ANGI
$760M
| $97.6M | ﹤0.01% |
6,397,657
+6,246,533
| +4,133% | +$95.3M |
|
|
BRSL
2042
Brightstar Lottery PLC
BRSL
$3.12B
| $97.4M | ﹤0.01% |
6,161,589
-278,608
| -4% | -$4.4M |
|
2043
LegalZoom.com
LZ
$1.9B
| $97.3M | ﹤0.01% |
10,915,036
+1,746,413
| +19% | +$15.6M |
|
2044
Industrial Select Sector SPDR Fund
XLI
$23.3B
| $97.2M | ﹤0.01% |
659,054
-70,407
| -10% | -$10.4M |
|
2045
Univest Financial
UVSP
$886M
| $97.1M | ﹤0.01% |
3,232,855
-185,113
| -5% | -$5.56M |
|
2046
Banco Bradesco
BBD
$33.1B
| $97M | ﹤0.01% |
31,394,053
+1,466,530
| +5% | +$4.53M |
|
|
WSR
2047
Whitestone REIT
WSR
$664M
| $97M | ﹤0.01% |
7,768,563
-518,632
| -6% | -$6.47M |
|
2048
Coastal Financial
CCB
$1.65B
| $96.9M | ﹤0.01% |
1,000,789
-46,544
| -4% | -$4.51M |
|
2049
Rocket Companies
RKT
$44.4B
| $96.9M | ﹤0.01% |
6,835,740
+1,237,511
| +22% | +$17.5M |
|
2050
SGHC Ltd
SGHC
$6.39B
| $96.8M | ﹤0.01% |
8,819,916
+330,155
| +4% | +$3.62M |
|